Federal Cannabis Legalization Bill Proposed In U.S. House

House Judiciary Committee Chairman Jerry Nadler (D-NY) reintroduced The Marijuana Opportunity Reinvestment and Expungement Act of 2021 on Friday.

If approved, the MORE Act — which was crafted with an emphasis on empowering states to enact their own cannabis policies — would remove penalties for cannabis possession, clear some cannabis-related criminal records, and establish social equity programs dedicated to repairing the communities most disadvantaged by the racist drug war and undoing other generational harms of cannabis prohibition…Read More

Cannabis Growers Consider Broader Options to Improve Facility Water Efficiency

Annual water usage for cannabis cultivation varies widely, depending on the type and scale of a given facility. Data from markets across the country show that indoor facilities use significantly more water per year than do greenhouse or outdoor facilities. However, the comparative usage rates do not necessarily indicate that indoor facilities are more inefficient in using their water than are those operating greenhouses or …Read More

Breaking News: Trusource helps customs for clients

NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today its branded nutraceutical manufacturer, Herbal Brands, has entered into a strategic partnership with the LooperGroup and TruSource Hemp Group (“TruSource”), a leading provider of services for the hemp industry, to import the Company’s first commercial shipment of CBD into the United States. Clever Leaves´ Colombian facilities are the first and only cannabis operations in LATAM to have a Good Manufacturing Practices certification from the European Union (EU-GMP). Read More…

Like CBD, but better

Cannabidiol (CBD) is all the rage in the wellness industry, but most large drugmakers are not interested in a molecule they can’t patent. A few start-ups and niche firms, however, are developing small molecules that are inspired by CBD and other natural products from cannabis plants as potential drugs for a wide… Read More